Completed NA INTERVENTIONAL 2-arm NCT01884233

Cell Phone Technology Targeting ART Adherence and Drug Use (TXT-CBT)

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Standard Care Text Messaging CBT (TXT-CBT)

Updated 7 times since 2017 Last updated: Apr 22, 2022 Started: Dec 31, 2012 Primary completion: Jan 31, 2016 Completion: Jan 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01884233, this NA trial focuses on HIV and Opioid Abuse and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 7 times since 2012, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2022 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE2 → NA
Jan 2021 — May 2022 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Active Not Recruiting PHASE2

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
University of California, Los Angeles

Data source: University of California, Los Angeles

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States